As shown in Fig. 3C, the level of cleaved caspase-3 was very low in cholangiocarcinoma cells treated with 10 μM of LY294002, 0.5 μM of RAD001 or oxaliplatin alone. This evidence concerns the gene CASP3 and cholangiocarcinoma.